AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial Growth AMSilk GmbH has successfully secured EUR 52 million financing led by existing investor ATHOS (AT Newtec), along with strong participation from fellow existing investors MIG Capital and Novo Holdings. The financing will enable AMSilk to scale industrial production and meet global customer demand for its […]
Firstly, congratulations to the team at Verona Pharma on their incredible $10bn dollar deal with Merck! And to Actithera on their oversubscribed $75.5M Series A – a great achievement in the current market. Huge congratulations also go to the incomparable Clive Cookson on receiving the Lifetime Achievement Award at the Association of British Science Writers […]
Challenges to pharma charging premium prices for branded drugs are not new. Think of President Biden’s attempts to drive down prices with the Inflation Reduction Act. Or the UK’s strategy of capping the price the NHS pays for branded medicines with its VPAG rebate scheme. But President Trump’s “most favoured nation” policy – which attempts […]
Well, the last fortnight’s certainly been a rollercoaster. Ever since President Trump announced his plans for sweeping tariffs on foreign goods entering the US on Thursday April 3, markets have hardly been able to catch their collective breath. First there was the initial shock, at which point stocks tanked, before lurching up and down, and […]
If a good rule of thumb for a conference is how full the hall is at the end of the day compared to the start, then the 21st Anglonordic Life Science Conference held last Thursday, attended by well over 300 people, was a resounding success. Maybe it was still full because attendees were keen to […]
